Indications

Livlyf is indicated for the treatment and prevention of- Liver disease (non-alcoholic & alcoholic) Fatty liver (non-alcoholic & alcoholic) Hepatitis Liver cirrhosis (non-alcoholic & alcoholic) Jaundice Liver fibrosis Drug-induced hepatotoxicity

Composition

• Silymarin (Extracted from Milk Thistle) BP 140 mg
• DL-alpha tocopherol acetate (Vitamin E) USP 200 IU.

Pharmacology

Silymarin, a flavonoid complex of Milk thistle, is the biologically active component. Silymarin is well known hepatoprotective agent. It is prepared with standardized extract of Milk Thistle fruits. Silymarin stimulates RNA polymerase-A, enhances protein synthesis and helps to regenerate and repair liver cell. It prevents toxic and foreign substances from penetrating into the liver cells by stabilizing the outer mem- brane of liver cells. Silymarin also acts by anti-lipid peroxidative, antifibrotic, anti-inflammatory, membrane stabilizing, immunomodulatory and liver regenerating mechanisms. Dl-alpha tocopherol acetate (Vitamin E) is a tocol which is one of the most potent anti- oxidant tocopherols. It exhibits antioxidant activity by virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus. Vitamin E has powerful antioxidant properties which can provide numerous benefits to the body, and may protect cells from oxidative damage.

Dosage & Administration

1 tablet 2 times daily or as directed by physician.

Contraindications

Contraindicated in patient with a known hypersensitivity to silymarin & vitamin E.

Side Effects

Well tolerated in recommended dose. Occasionally a mild laxative effect may observe.

Pregnancy & Lactation

Precautions & Warnings

Therapeutic Class

Herbal and Nutraceuticals

Storage Conditions

Store in a cool & dry place, away from light & moisture. Keep out of reach of children.